Safety and Tolerability of Repeat Courses of IM Alefacept

NCT00794807 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Chronic Plaque Psoriasis

Interventions

DRUG: Alefacept

Sponsor

Charite University, Berlin, Germany

Collaborators

[object Object]